Table 2 Dosimetric coverage of treatment volumes and OARs by treatment cohort

PTV_primary

HI

0.28 (0.10, 1.09), 0.51

0.14 (0.05, 0.36), 0.18

UI

1.06 (1.04, 1.52), 1.09

1.03 (1.01, 1.07), 1.03

PTV_node

HI

0.42 (0.14, 1.25), 0.48

0.55 (0.33, 0.79), 0.54

UI

1.12 (1.04, 1.52), 1.16

1.17 (1.09, 1.21), 1.16

Bladder

V30

94 (51, 100), 88.8

100 (94, 100), 99

V40

56.5 (13, 92), 55.5

96 (44, 100), 90.9

V50

14 (0.9, 54), 17.5

28 (0.2, 35), 21

Mean (Gy)

40.9 (32.4, 49.5), 41.3

47 (38.3, 49.2), 46.5

Median (Gy)

41.6 (30.3, 51.1), 41.5

47.1 (37.1, 49.0), 46.5

Bone Marrow

V10

82.5 (47, 98), 78.6

67 (63, 75), 67.4

V20

62.5 (22, 88), 60.9

56 (51, 60), 56

Mean (Gy)

27.6 (12.4, 37.4), 27.2

26.2 (23.1, 28.5), 26.3

Median (Gy)

29.4 (9.1, 44.3), 28.9

28.3 (21.1, 33.4), 28.3

Femoral heads

V30

68.5 (15, 99), 63.7

91 (76, 100), 90.3

V40

14.5 (0, 50), 15.3

47 (27, 67), 50

V50

0 (0, 14), 1.2

0 (0, 26), 3.1

Mean (Gy)

32 (23.5, 41.9), 31.5

38.9 (35.4, 44.1), 39.1

Median (Gy)

32.7 (23.6, 40.2), 31.6

39.3 (35.2, 43.2), 39.8

Peritoneal Cavity

V30

26.5 (0.1, 66), 30.7

46 (6, 76), 44.6

V40

11 (0.9, 53), 17.2

34 (2, 66), 32.5

V45

4.5 (0, 44), 9.2

22 (0.5, 57), 23.4

V50

0.9 (0, 17), 1.7

2 (0, 27), 4.1

Mean (Gy)

20.2 (4.7, 36.4), 20.4

26.3 (9, 40.6), 25.6

Median (Gy)

19.7 (2.3, 41.8), 19.3

26 (4.1, 45.7), 25.4

External Genitalia

V20

98.5 (62, 100), 91

73 (48, 98), 73.7

V30

64 (19, 99), 65

25 (6, 58), 27.1

V40

27 (0, 86), 25.7

5 (0, 48), 9.8

V50

2 (0, 44), 7.2

0.9 (0, 39), 4.4

Mean (Gy)

33.6 (21.8, 47.6), 33.6

25.1 (18, 38.9), 26

Median (Gy)

33.3 (23.9, 48.9), 33.6

23.4 (18.9, 35.2), 24

Skin

Mean (Gy)

17 (1.4, 21.3), 16

23.1 (11.2, 26.8), 22

Median (Gy)

15.9 (11.9, 19.2), 15.9

20.4 (6, 23.4), 19.1